Abstract
Prolonged agonist stimulation of the μ-opioid receptor (MOR) initiates receptor regulatory events that rapidly attenuate receptor-mediated signaling (homologous desensitization). Emerging evidence suggests that persistent MOR stimulation can also reduce responsiveness of effectors to other G-protein-coupled receptors, termed heterologous desensitization. However, the mechanisms by which heterologous desensitization is triggered by MOR stimulation are unclear. This study used whole-cell patch-clamp recordings of ligand activated G-protein-activated inwardly rectifying potassium channel currents in mouse brain slices containing locus ceruleus (LC) neurons to determine the effects of prolonged stimulation of MOR on α2-adrenoceptor (α2-AR) function. The results show distinct and sequential development of homologous and heterologous desensitization during persistent stimulation of MOR in LC neurons with Met5-enkephalin (ME). ME stimulation of MOR promoted rapid homologous desensitization that reached a steady state after 5 min and partially recovered over 30 min. Longer stimulation of MOR (10 min) induced heterologous desensitization of α2-AR function that exhibited slower recovery than homologous desensitization. Heterologous (but not homologous) desensitization required β-arrestin-2 (βarr-2) because it was nearly abolished in βarr-2-knockout (ko) mice. Heterologous (but not homologous) desensitization was also prevented by inhibition of ERK1/2 and c-Src signaling in wild-type (wt) mouse LC neurons. Heterologous desensitization may be physiologically relevant during exposure to high doses of opioids because α2-AR-mediated slow inhibitory postsynaptic currents were depressed in wt but not βarr-2 ko LC neurons after prolonged exposure to opioids. Together, these findings demonstrate a novel mechanism by which βarr-2 can regulate postsynaptic responsiveness to neurotransmitter release.
Footnotes
This work was Supported by the National Health and Medical Research Council of Australia [Grants 1011979, 511914].
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS:
- MOR
- μ-opioid receptor
- GRK
- G-protein-coupled receptor kinases
- ERK1/2
- extracellular signal regulated kinases 1 and 2
- GIRK
- G protein-activated inwardly rectifying potassium channel
- α2-AR
- α2-adrenergic receptor
- GPCR
- G protein-coupled receptor
- ME
- Met5-enkephalin
- LC
- locus ceruleus
- βarr-2
- β-arrestin-2
- c-Src
- cellular Src
- NA
- noradrenaline
- wt
- wild type
- MES
- 2-(morpholino)-ethanesulfonic acid
- BAPTA
- 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid
- sIPSC
- slow inhibitory postsynaptic current
- MK801
- dizocilpine maleate
- UK14304
- brimonidine tartrate
- PP2
- 4-amino-5-(4-chlorophenyl)-(t-butyl)pyrazolo[3,4-d]pyrimidine
- PD98059
- 2′-amino-3′-methoxyflavone
- U0126
- 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene
- ko
- knockout
- DYNi
- dynamin inhibitory peptide.
- Received April 15, 2012.
- Accepted June 11, 2012.
- Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|